Compare ARDX & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | RXT |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2014 | 2020 |
| Metric | ARDX | RXT |
|---|---|---|
| Price | $4.05 | $4.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $15.14 | $1.71 |
| AVG Volume (30 Days) | 2.6M | ★ 12.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.13 |
| EPS | N/A | ★ 0.03 |
| Revenue | $2,607,000.00 | ★ $2,685,700,000.00 |
| Revenue This Year | $37.75 | N/A |
| Revenue Next Year | $34.24 | $1.35 |
| P/E Ratio | ★ N/A | $161.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.71 | $0.39 |
| 52 Week High | $8.40 | $8.60 |
| Indicator | ARDX | RXT |
|---|---|---|
| Relative Strength Index (RSI) | 34.44 | 51.57 |
| Support Level | N/A | $3.78 |
| Resistance Level | $6.47 | $6.15 |
| Average True Range (ATR) | 0.16 | 0.36 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 12.09 | 77.71 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.